ARUP Laboratories has launched the clinical CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry assay for multiple ...

Welcome to the spectral flow cytometry handbook, an essential resource for researchers in the field of flow cytometry. This ...

ARUP Laboratories today announced the launch of ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry. The new assay will characterize small neoplastic populations with greater confidence ...

AI flow cytometry analysis has become the default approach for cell population discovery once a panel outgrows what a scientist can gate by eye. Manual gating does not scale to today's high-parameter ...

Jul 22, 2026--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics and targeted the ...

Thymulin reduced age-associated inflammatory myeloid cells and slowed breast-tumor growth in aged mice by suppressing NF-κB ...

Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational applications.

A fading hormone may unlock clues to aging and cancer defenses, but scientists warn the breakthrough comes with major ...

NeoGenomics pay s $9.8 million to settle allegations it offered discounted services to secure patient referrals.

Under the agreement, bioAffinity’s sputum analysis will be combined with Pictor’s proteomic platform to analyse inflammation.

NeoGenomics Laboratories Inc., headquartered in Florida, will pay $9,813,260 to settle allegations that it provided ...